Incidence of Snake Bites in Kashan, Iran During an Eight Year Period (2004-2011)

Background: Snake bites are one of the significant health problems in the tropical and subtropical regions. Snake bite is a common medical emergency in Iran, and the epidemiological features and management of such cases vary from region to region. Objectives: This present research study was conducted to obtain new information about the epidemiology of snake bites in the region of Kashan, located in the central part of Iran. Patients and Methods: This research was a descriptive retrospective study. Data from 2004 to 2011 of snakebite cases were collected from case reports. Information included; age and sex of the victim, district, month of incident, mortality, and time of bite. Results: The results of this study showed that the majority of snake bite patients were male (96%). The age distribution of patients indicated that the greatest rate of snake bites occurred among the 15-24 year old group. Data collected in this study revealed that the highest incidence of snake bite cases took place in summer (60%) and the lowest number occurred in winter, with no snake bite cases being recorded. The peak number of snakebite cases was seen during June-September. Conclusions: It was concluded that snake bite cases in Kashan are similar to other areas in Iran from an epidemiological point of view, including; age distribution rates, gender and site of the bites. The existence of Macrov ipera lebetina, a dangerous venomous snake, can cause a range of clinical effects among residents in central parts of Iran, such as Kashan area

The Preventive/Protective Effect of Testosterone on Haloperidol-Induced Extrapyramidal Disorders in Male Rats

BACKGROUND AND OBJECTIVE: Many non-motor symptoms of Parkinson's disease such as depression are associated with testosterone deficiency. On the other hand, the effect of testosterone therapy on the motor symptoms of Parkinson's disease is unknown. Therefore, the present study was conducted to evaluate the effect of testosterone on haloperidol-induced extrapyramidal disorders. METHODS: In this experimental study, 60 male Wistar rats weighing 180–220 g were randomly divided into 10 groups of 6. Rats were intraperitoneally pretreated with saline, polyethylene glycol, flutamide (10 mg/kg) or testosterone (1 mg/kg) for 1 or 7 consecutive days and before administration of haloperidol. The effects of testosterone and flutamide on catalepsy and motor disorder caused by haloperidol were measured by bar test and rotarod test, respectively. FINDINGS: Haloperidol (1 mg/kg) significantly (p<0.004) resulted in catalepsy (170±17.25) and balance impairment (52±8). Pretreatment with testosterone for 7 days had a preventive effect on haloperidol-induced extrapyramidal disorders and improved catalepsy (55±8) (p<0.001) and balance impairment (178±8) (p<0.05) in mice, whereas co-administration of flutamide prevented the ameliorative effects of testosterone on extrapyramidal disorders. CONCLUSION: The results of the study showed that pretreatment with testosterone has a significant effect on the improvement of catalepsy

Two Inputs Five-Level Quasi-Z-Source Inverter

This paper combines quasi-Z-source into a typical five-level inverter, which includes two dc voltage sources, two quasi-Z-sources and five switching devices. In this structure, the output voltage amplitude is not limited to dc voltage source and it can be increased by quasi-Z-source. Besides, due to nature of Z-source families, this new structure is reliable and higher efficiency. Also, in this inverter, two quasi-Z-networks can be controlled independently. This paper also proposes new switching algorithms for proposed five-level dual quasi-Z-Source inverter based on pulse width modulation (PWM) and selective harmonic elimination method (SHEM) algorithms .The performance of proposed inverter and switching algorithm are validated with simulation results using MATLAB/SIMULINK software and experimental results based PCI-1716 data acquisition system

Independent Review Support for Phoenix Mars Mission Robotic Arm Brush Motor Failure

The Phoenix Project requested the NASA Engineering and Safety Center (NESC) perform an independent peer review of the Robotic Arm (RA) Direct Current (DC) motor brush anomalies that originated during the Mars Exploration Rover (MER) Project and recurred during the Phoenix Project. The request was to evaluate the Phoenix Project investigation efforts and provide an independent risk assessment. This includes a recommendation for additional work and assessment of the flight worthiness of the RA DC motors. Based on the investigation and findings contained within this report, the IRT concurs with the risk assessment Failure Cause / Corrective Action (FC/CA) by the project, "Failure Effect Rating "3"; Major Degradation or Total Loss of Function, Failure Cause/Corrective Action Rating Currently "4"; Unknown Cause, Uncertainty in Corrective Action.

Accuracy and efficiency of conventional ground sprayers in Iran

Sunn pest, Eurygaster integriceps, is a key pest of wheat and barley in Iran. At present, infested areas are treated with ground sprayers. A survey was conducted to evaluate the efficiency and calibration accuracy of ground hydraulic sprayers in Iran. The results showed that the motorized lance sprayer and manually operated sprayer were the most conventional sprayers, and fenitrothion EC 50% and deltamethrin EC 2.5% were the conventional insecticides against sunn pest in Kermanshah province. The mean efficacy percentage was 88% and 35% against nymphs and overwintered adults, respectively. In motorized lance sprayers, there were 5% and 90% overdosage of fenitrothion and deltamethrin, respectively; while, in manually carried sprayers, there were 5% and 25% overdosage of fenitrothion and deltamethrin, respectively. Applied dosages were 5-20% and 25-90% more than recommended dosages of fenitrothion and deltamethrin, respectively. Errors in effectiveness and applied dosage were higher in motorized lance sprayer than manually carried sprayers

Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies

Accumulating evidence indicates that neutralizing antibodies play an important role in protection from chronic hepatitis C virus (HCV) infection. Efforts to elicit such responses by immunization with intact heterodimeric E1E2 envelope proteins have met with limited success. To determine whether antigenic sites, which are not exposed by the combined E1E2 heterodimer structure, are capable of eliciting neutralizing antibody responses, we expressed and purified each as separate recombinant proteins E1 and E2, from which the immunodominant hypervariable region (HVR-1) was deleted. Immunization of chimpanzees with either E1 or E2 alone induced antigen-specific T-helper cytokines of similar magnitude. Unexpectedly, the capacity to neutralize HCV was observed in E1 but not in animals immunized with E2 devoid of HVR-1. Furthermore, in vivo only E1-vaccinated animals exposed to the heterologous HCV-1b inoculum cleared HCV infection

Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes

OBJECTIVES—To investigate a B-cell–depleting strategy to reverse diabetes in naïve NOD mice

The potential utility of B cell-directed biologic therapy in autoimmune diseases

Increasing awareness of the importance of aberrant B cell regulation in autoimmunity has driven the clinical development of novel B cell-directed biologic therapies with the potential to treat a range of autoimmune disorders. The first of these drugs—rituximab, a chimeric monoclonal antibody against the B cell-specific surface marker CD20—was recently approved for treating rheumatoid arthritis in patients with an inadequate response to other biologic therapies. The aim of this review is to discuss the potential use of rituximab in the management of other autoimmune disorders. Results from early phase clinical trials indicate that rituximab may provide clinical benefit in systemic lupus erythematosus, Sjögren’s syndrome, vasculitis, and thrombocytopenic purpura. Numerous case reports and several small pilot studies have also been published reporting the use of rituximab in conditions such as myositis, antiphospholipid syndrome, Still’s disease, and multiple sclerosis. In general, the results from these preliminary studies encourage further testing of rituximab therapy in formalized clinical trials. Based on results published to date, it is concluded that rituximab, together with other B cell-directed therapies currently under clinical development, is likely to provide an important new treatment option for a number of these difficult-to-treat autoimmune disorders

Human cell types important for Hepatitis C Virus replication in vivo and in vitro. Old assertions and current evidence

Hepatitis C Virus (HCV) is a single stranded RNA virus which produces negative strand RNA as a replicative intermediate. We analyzed 75 RT-PCR studies that tested for negative strand HCV RNA in liver and other human tissues. 85% of the studies that investigated extrahepatic replication of HCV found one or more samples positive for replicative RNA. Studies using in situ hybridization, immunofluorescence, immunohistochemistry, and quasispecies analysis also demonstrated the presence of replicating HCV in various extrahepatic human tissues, and provide evidence that HCV replicates in macrophages, B cells, T cells, and other extrahepatic tissues. We also analyzed both short term and long term in vitro systems used to culture HCV. These systems vary in their purposes and methods, but long term culturing of HCV in B cells, T cells, and other cell types has been used to analyze replication. It is therefore now possible to study HIV-HCV co-infections and HCV replication in vitro